Amalgamated Bank Increases Stock Position in Colgate-Palmolive (NYSE:CL)

Amalgamated Bank lifted its holdings in Colgate-Palmolive (NYSE:CL) by 6.6% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 182,571 shares of the company’s stock after purchasing an additional 11,377 shares during the period. Amalgamated Bank’s holdings in Colgate-Palmolive were worth $18,953,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. bought a new position in shares of Colgate-Palmolive in the 2nd quarter worth approximately $25,000. Continuum Advisory LLC lifted its stake in shares of Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the period. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $42,000. Gradient Investments LLC lifted its stake in shares of Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after purchasing an additional 400 shares during the period. Finally, Financial Connections Group Inc. bought a new position in shares of Colgate-Palmolive in the 2nd quarter worth approximately $68,000. Institutional investors own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CL shares. TD Cowen decreased their target price on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Hsbc Global Res cut shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Barclays raised their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Finally, UBS Group raised their target price on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $105.11.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the transaction, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.37% of the stock is owned by insiders.

Colgate-Palmolive Trading Up 0.3 %

CL stock opened at $93.61 on Tuesday. The firm has a fifty day moving average price of $102.03 and a 200 day moving average price of $98.40. Colgate-Palmolive has a fifty-two week low of $74.67 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The firm has a market cap of $76.48 billion, a PE ratio of 26.82, a price-to-earnings-growth ratio of 3.33 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.14%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.